Magar SD, Pawar PY. In silico ADMET screening & molecular docking of some 1-(5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl) ethanone derivatives to be developed as triple mutant T790M/C797S EGFR inhibitors. Int. J. of Health Sci. [Internet]. 2022 Jun. 22 [cited 2026 May 10];6(S3):10432-51. Available from: https://sciencescholar.us/journal/index.php/ijhs/article/view/9448